Gabapentin Oral solution

Form: Oral solution

Strength: 250 mg/5 mL

Reference Brands: US: Neurontin®, Gralise®, Horizant® (ER); EU: Neurontin®, Gabantin®

Category: Antipsychotropic Drugs

Gabapentin oral solution is FDA-approved in the USA for treating partial seizures and postherpetic neuralgia. It is available as a prescription medication under the Federal Food, Drug, and Cosmetic Act, with specific guidelines for renal dose adjustment and CNS-related adverse effects. In the European Union, gabapentin is authorized via national procedures for epilepsy and neuropathic pain, with country-specific brand names and formulations. EU labeling includes warnings for CNS depression, suicidal ideation, and withdrawal symptoms. It’s classified as a prescription-only medicine (POM). To explore global availability and sourcing, visit Pharmatradz.com